795 related articles for article (PubMed ID: 15936576)
21. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
[TBL] [Abstract][Full Text] [Related]
22. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
25. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
[TBL] [Abstract][Full Text] [Related]
26. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.
De Leeuw AA; Moerland MA; Nomden C; Tersteeg RH; Roesink JM; Jürgenliemk-Schulz IM
Radiother Oncol; 2009 Nov; 93(2):341-6. PubMed ID: 19515443
[TBL] [Abstract][Full Text] [Related]
27. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
28. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
[TBL] [Abstract][Full Text] [Related]
29. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
[TBL] [Abstract][Full Text] [Related]
30. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
31. [Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer].
Haie-Meder C; Mazeron R; Verezesan O; Dumas I; Monnier L; Vieillot S; Lhommé C; Morice P; Barillot I
Cancer Radiother; 2009 Oct; 13(6-7):520-4. PubMed ID: 19762262
[TBL] [Abstract][Full Text] [Related]
32. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.
Dewitt KD; Hsu IC; Speight J; Weinberg VK; Lessard E; Pouliot J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1270-4. PubMed ID: 16253782
[TBL] [Abstract][Full Text] [Related]
33. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
34. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
[TBL] [Abstract][Full Text] [Related]
35. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer.
Kirisits C; Lang S; Dimopoulos J; Oechs K; Georg D; Pötter R
Radiother Oncol; 2006 Dec; 81(3):269-75. PubMed ID: 17126938
[TBL] [Abstract][Full Text] [Related]
36. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
37. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
[TBL] [Abstract][Full Text] [Related]
38. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
39. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
